These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 28836580)

  • 1. BCR-ABL1-positive microvesicles malignantly transform human bone marrow mesenchymal stem cells in vitro.
    Fu FF; Zhu XJ; Wang HX; Zhang LM; Yuan GL; Chen ZC; Li QB
    Acta Pharmacol Sin; 2017 Nov; 38(11):1475-1485. PubMed ID: 28836580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-146b-5p within BCR-ABL1-Positive Microvesicles Promotes Leukemic Transformation of Hematopoietic Cells.
    Zhang HM; Li Q; Zhu X; Liu W; Hu H; Liu T; Cheng F; You Y; Zhong Z; Zou P; Li Q; Chen Z; Guo AY
    Cancer Res; 2016 May; 76(10):2901-11. PubMed ID: 27013199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of cellular and immune-related properties of bone marrow mesenchymal stem cells and macrophages by K562 chronic myeloid leukemia cell derived exosomes.
    Jafarzadeh N; Safari Z; Pornour M; Amirizadeh N; Forouzandeh Moghadam M; Sadeghizadeh M
    J Cell Physiol; 2019 Apr; 234(4):3697-3710. PubMed ID: 30317554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microvesicles derived from normal and multiple myeloma bone marrow mesenchymal stem cells differentially modulate myeloma cells' phenotype and translation initiation.
    Dabbah M; Attar-Schneider O; Tartakover Matalon S; Shefler I; Jarchwsky Dolberg O; Lishner M; Drucker L
    Carcinogenesis; 2017 Jul; 38(7):708-716. PubMed ID: 28838065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of primary mesenchymal precursors and hematopoietic bone marrow cells from chronic myeloid leukemia patients by BCR-ABL1 fusion gene.
    Chandia M; Sayagués JM; Gutiérrez ML; Chillón ML; Aristizábal JA; Corrales A; Castellanos M; Melón A; Sánchez ML; Bárcena P; Matarraz S; González-González M; Barrena S; López A; Cañizo MC; Sánchez-Guijo F; Orfao A
    Am J Hematol; 2014 Mar; 89(3):288-94. PubMed ID: 24779036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCR-ABL1-positive microvesicles transform normal hematopoietic transplants through genomic instability: implications for donor cell leukemia.
    Zhu X; You Y; Li Q; Zeng C; Fu F; Guo A; Zhang H; Zou P; Zhong Z; Wang H; Wu Y; Li Q; Kong F; Chen Z
    Leukemia; 2014 Aug; 28(8):1666-75. PubMed ID: 24480987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
    Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epigenetic effect of microRNA in BCR-ABL1‑positive microvesicles during the transformation of normal hematopoietic transplants.
    Shen N; Jiang L; Li Q; Cui J; Zhou S; Cheng F; Zhong Z; Meng L; You Y; Zhu X; Zou P
    Oncol Rep; 2017 Nov; 38(5):3278-3284. PubMed ID: 29048642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral blood vs. bone marrow for molecular monitoring of BCR-ABL1 levels in chronic myelogenous leukemia, a retrospective analysis in allogeneic bone marrow recipients.
    Ballestrero A; Cirmena G; Dominietto A; Garuti A; Rocco I; Cea M; Moran E; Nencioni A; Miglino M; Raiola AM; Bacigalupo A; Patrone F
    Int J Lab Hematol; 2010 Aug; 32(4):387-91. PubMed ID: 19968720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purging efficacy of ZnPcH₁-based photodynamic therapy on chronic myeloid leukemia bone marrow.
    Huang H; Chen Y; Chen W; Wu Y
    Int J Lab Hematol; 2011 Oct; 33(5):477-82. PubMed ID: 21457188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-β1 and CXCL12 modulate proliferation and chemotherapy sensitivity of acute myeloid leukemia cells co-cultured with multipotent mesenchymal stromal cells.
    Schelker RC; Iberl S; Müller G; Hart C; Herr W; Grassinger J
    Hematology; 2018 Jul; 23(6):337-345. PubMed ID: 29140182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basic knowledge on BCR-ABL1-positive extracellular vesicles.
    Jurj A; Pasca S; Teodorescu P; Tomuleasa C; Berindan-Neagoe I
    Biomark Med; 2020 Apr; 14(6):451-458. PubMed ID: 32270699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentially expressed microRNAs in bone marrow mesenchymal stem cell-derived microvesicles in young and older rats and their effect on tumor growth factor-β1-mediated epithelial-mesenchymal transition in HK2 cells.
    Wang Y; Fu B; Sun X; Li D; Huang Q; Zhao W; Chen X
    Stem Cell Res Ther; 2015 Sep; 6():185. PubMed ID: 26415502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells from patients with chronic myeloid leukemia do not express BCR-ABL and have absence of chimerism after allogeneic bone marrow transplant.
    Carrara RC; Orellana MD; Fontes AM; Palma PV; Kashima S; Mendes MR; Coutinho MA; Voltarelli JC; Covas DT
    Braz J Med Biol Res; 2007 Jan; 40(1):57-67. PubMed ID: 17224997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gene of DNA-dependent protein kinase catalylic subunit in chronic myeloid leukemia].
    Luo J; Peng ZG; Chen Y; Lai YR; Lu YY; Song SJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):248-52. PubMed ID: 17493325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of bone marrow mesenchymal stem cells from blastic phase chronic myelogenous leukemia on the growth and apoptosis of leukemia cells.
    Han Y; Wang Y; Xu Z; Li J; Yang J; Li Y; Shang Y; Luo J
    Oncol Rep; 2013 Aug; 30(2):1007-13. PubMed ID: 23733230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased microRNA-30a levels are associated with enhanced ABL1 and BCR-ABL1 expression in chronic myeloid leukemia.
    Liu Y; Song Y; Ma W; Zheng W; Yin H
    Leuk Res; 2013 Mar; 37(3):349-56. PubMed ID: 23287430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of anti-bcr-abl hammerhead ribozyme on bone marrow purging].
    Wu Y; Chen YZ; Huang HF; Chen P; Lu LH
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Sep; 35(9):859-63. PubMed ID: 12958661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of BCR-ABL1 quantification in peripheral blood and bone marrow using an International Scale-standardized assay for assessment of deep molecular response in chronic myeloid leukemia.
    Greiner G; Ratzinger F; Gurbisz M; Witzeneder N; Taghizadeh H; Mustafa SGK; Mitterbauer-Hohendanner G; Esterbauer H; Mannhalter C; Sperr WR; Valent P; Hoermann G
    Clin Chem Lab Med; 2020 Jul; 58(8):1214-1222. PubMed ID: 32084002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCR/ABL oncogene-induced PI3K signaling pathway leads to chronic myeloid leukemia pathogenesis by impairing immuno-modulatory function of hemangioblasts.
    Li Q; Wu Y; Fang S; Wang L; Qi H; Zhang Y; Zhang J; Li W
    Cancer Gene Ther; 2015 May; 22(5):227-37. PubMed ID: 25837664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.